title: Concurrent cytomegalovirus and herpes simplex virus infection in pemphigus vulgaris treated with rituximab and prednisolone.
authors.forename: Hsien-Yi
authors.initials: HY
authors.lastname: Chiu
authors.forename: Chia-Ying
authors.initials: CY
authors.lastname: Chang
authors.forename: Cheng-Hsiang
authors.initials: CH
authors.lastname: Hsiao
authors.forename: Li-Fang
authors.initials: LF
authors.lastname: Wang
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D001706:Biopsy; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000821:virology*; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000009:adverse effects*; D006561:Herpes Simplex / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000821:virology*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D010392:Pemphigus / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011239:Prednisolone / Q000009:adverse effects*; D000069283:Rituximab; D012867:Skin / Q000187:drug effects / Q000473:pathology / Q000821:virology; D016896:Treatment Outcome; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000998:Antiviral Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000069283:Rituximab; D011239:Prednisolone; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir